Tenon Medical (TNONW) Cash & Equivalents (2021 - 2026)

Tenon Medical has reported Cash & Equivalents for 6 years, with the latest figure at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 55.32% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $4.6 million (down 55.32% YoY), and the FY2025 full-year result was $3.8 million, down 42.52% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $4.6 million, up from $3.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $10.3 million in Q1 2025, with the low at $2.0 million in Q2 2024.
• Average Cash & Equivalents over 5 years is $5.0 million, with a median of $4.4 million recorded in 2024.
• Year-over-year, Cash & Equivalents slumped 66.37% in 2024 and surged 298.68% in 2025.
• Tracing TNONW's Cash & Equivalents over 5 years: stood at $2.1 million in 2022, then grew by 14.04% to $2.4 million in 2023, then surged by 169.15% to $6.5 million in 2024, then sank by 42.52% to $3.8 million in 2025, then advanced by 22.66% to $4.6 million in 2026.
• The last three Cash & Equivalents figures came in at $4.6 million (Q1 2026), $3.8 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.

Peer Comparison